Nanostics Announces Launch of its Clinical Validation Study for ClarityDX Prostate. Nanostics Inc. is developing a novel liquid biopsy platform for the early diagnosis of clinically significant prostate cancer, is pleased to announce the start of its key clinical validation study
Come Visit Apogee at #ASMMicrobe2016 in booth 1557! Learn how #microbiology and #flowcytometry can work together.
Visit Apogee in booth 721 at #CYTO2016! See the latest in small particle #flowcytometry and receive a helpful gift!
Come visit Apogee at ISEV 2016 and see how our small particle flow cytometer can accelerate your research! #flowcytometry #ISEV #ISEV2016
Come see Apogee at Pittcon booth 560 and see the latest in small particle flow cytometry #pittcon2016 #flowcytometry
ApogeeFlow retweeted
Former Military Tool to Target #ProstateCancer bit.ly/1TIOup6 @westernu @ApogeeFlow #FlowCytometer #Alzheimers #GulfWar #usmarines
Happy Valentine's Day from Apogee Flow Systems! Thanks for the inspiration @CellSignal
Come meet Apogee and see the latest in #flowcytometry developments on Feb 4 at the #NIH FCIG Winter Meeting!
Today's #ThrowbackThursday paper from 2005 shows Apogee cytometers are used in archaea. See more at goo.gl/cipF1e #flowcytometry
The world of extracellular vesicle analysis has gotten easier! See how at facebook.com/apogeeflow









